Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.1%

6 terminated/withdrawn out of 195 trials

Success Rate

95.7%

+9.2% vs industry average

Late-Stage Pipeline

20%

39 trials in Phase 3/4

Results Transparency

27%

37 of 135 completed trials have results

Key Signals

25 recruiting37 with results

Enrollment Performance

Analytics

N/A

95(58.6%)

Phase 4

24(14.8%)

Phase 2

18(11.1%)

Phase 3

15(9.3%)

Phase 1

10(6.2%)

162Total

N/A(95)

Phase 4(24)

Phase 2(18)

Phase 3(15)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (195)

Showing 20 of 195 trials

NCT05549726Phase 4Completed

SEARCH CAB LA Dynamic Choice HIV Prevention Study Extension

Role: collaborator

NCT05117788Recruiting

Bioneer Q-RFIA Clinical Evaluation

Role: collaborator

NCT06898203Not ApplicableRecruiting

Precision Imaging to Evaluate Kaposi Sarcoma

Role: collaborator

NCT06213051Suspended

Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV Detection

Role: collaborator

NCT06566417Completed

Social Media as a Risk Tool for HIV Prevention Needs

Role: collaborator

NCT05994742Phase 3Completed

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

Role: collaborator

NCT04825782Completed

MiMBa Pregnancy Registry

Role: collaborator

NCT06601712Phase 4Recruiting

Post-discharge Malaria Chemoprevention Implementation Trial in Benin

Role: collaborator

NCT06523231Phase 2Completed

Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants.

Role: collaborator

NCT05754658Completed

African Cancer Genome: GMD

Role: collaborator

NCT07076043Phase 4Recruiting

Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention

Role: collaborator

NCT06036238Not ApplicableActive Not Recruiting

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)

Role: collaborator

NCT06085105Not ApplicableCompleted

Caring for Providers to Improve Patient Experience (CPIPE) Trial

Role: collaborator

NCT04432571Not ApplicableCompleted

ADAPT for Adolescents Adolescents

Role: collaborator

NCT04056117Phase 1Completed

A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants

Role: collaborator

NCT05140954Phase 2Completed

The Women TAF-FTC Benchmark Study

Role: collaborator

NCT05057858Phase 2Completed

The Women TDF-FTC Benchmark Study

Role: collaborator

NCT05904145Recruiting

PRISMA Maternal and Newborn Health Study

Role: collaborator

NCT06687746Completed

Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns

Role: collaborator

NCT06519994Phase 2Completed

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Role: collaborator